News

Mandatory notification of trade

Change in the board of directors

Mandatory notification of trade

Change of employment status for senior VP

Mandatory notification of trade

Reimbursement of Genefec

Nordiag Q2 2007

Presentation of the second quarter 2007

Letter to the shareholders

Case study from NorDiag published in August

Oslo Børs - Matching halt ends

Oslo Børs - Matching halt

Public reimbursement of the Genefec test discontinued in Norway from 1 September

EXACT Sciences and NorDiag Announce International Collaboration and License Agreement for Colorectal Cancer

NorDiag has entered into a distribution agreement with Roche

Mottatt firmaattest

NorDiag: New product for tailored medicine

Pages